Revenue ₹2,692 Cr (+12.1% YoY)
Diversified
Tracked since Q1 FY24 - Q3 FY26
Divislab Ltd
DIVISLAB
0 met · 0 close · 9 missed across 9 tracked promises
View all executive profiles for Divislab LtdDivis Laboratories reported Q3 FY26 consolidated total income of INR 2,692 crore, up 12% YoY, driven by strong custom...
0% promises delivered
Based on 9 tracked promises across 10 quarters
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Quarterly Earnings Timeline
Financial verification status, call summary, sentiment, and management-delivery signals by quarter.
Q3 FY26
15 Jan 2026
Revenue ₹2,692 Cr (+12.1% YoY)
Divis Laboratories reported Q3 FY26 consolidated total income of INR 2,692 crore, up 12% YoY, driven by strong custom synthesis (57% mix) and stable generics volume.
bullish
medium
2 missed
Read full analysis →
Q2 FY26
30 Oct 2025
Revenue ₹2,860 Cr (+17% YoY)
Divis Laboratories reported a strong Q2 FY26 with consolidated revenue of INR 2,860 crore (+17% YoY) and PAT of INR 689 crore (+35% YoY), driven by robust custom synth...
bullish
medium
1 missed
Read full analysis →
Q1 FY26
30 Jul 2025
Revenue pending filing verification
Divis Laboratories reported a strong Q1 FY26 with PAT rising 26.7% YoY to INR 545 crore, driven by robust custom synthesis traction and backward integration benefits.
bullish
medium
1 missed
Read full analysis →
Q4 FY25
30 Apr 2025
Revenue pending filing verification
Divis Laboratories reported a strong Q4 FY25 with PAT of INR 662 crore, up 23% YoY, driven by robust custom synthesis momentum and stable generic volumes despite prici...
bullish
medium
1 missed
Read full analysis →
Q3 FY25
30 Jan 2025
Revenue pending filing verification
Divis Laboratories reported a strong Q3 FY25 with PAT of INR 589 crore, up 64.5% YoY, driven by robust custom synthesis growth and stable generics volumes.
bullish
medium
1 missed
Read full analysis →
Q2 FY25
22 Oct 2024
Revenue pending filing verification
Divis Labs reported a strong Q2 FY25 with PAT surging 46.6% YoY to INR 510 Cr, driven by robust custom synthesis demand and operational efficiencies.
bullish
high
1 missed
Read full analysis →
Q1 FY25
30 Jul 2024
Revenue ₹2,197 Cr (+18% YoY)
Divis Labs reported a steady Q1 FY25 with consolidated revenue of INR 2,197 crore, up 18% YoY, and PAT of INR 430 crore, up 21% YoY.
bullish
medium
Scorecard starts after historical backfill
Read full analysis →
Q3 FY24
24 Jan 2024
Revenue pending filing verification
Divis Laboratories reported a steady Q3 FY24 with PAT of INR 358 crore on total income of INR 1,950 crore.
neutral
medium
1 missed
Read full analysis →
Q2 FY24
30 Oct 2023
Revenue pending filing verification
Divis Laboratories reported Q2 FY24 consolidated PAT of INR 348 crore on total income of INR 1,995 crore, with export share at 87%.
neutral
medium
1 missed
Read full analysis →
Q1 FY24
10 Aug 2023
Revenue pending filing verification
Divis Laboratories reported a consolidated total income of INR 1,859 crore for Q1 FY24, down from INR 2,343 crore in the same quarter last year, reflecting the absence...
neutral
medium
Scorecard starts after historical backfill
Read full analysis →